Dr. Reddy's Laboratories Ltd Common Stock (RDY)
EBITDA Growth
-66.14%
Quarterly · Period ending:
RDY EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-66.14%period ending
Latest reported-66.14%period ending
RDY Quarterly EBITDA YoY % (100.30% → -66.14%)
Year-over-year change
High-resolution chart · PNG
RDY ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -66.141% | |
| -65.3334% | |
| -18.7693% | |
| 1.7114% | |
| 13.2601% | |
| 24.3185% | |
| 8.2869% | |
| 493.8823% | |
| 2.5886% | |
| 505.9863% | |
| 11.9092% | |
| 20.8472% | |
| 17.4828% | |
| 12.016% | |
| 55.3101% | |
| 5.5137% | |
| 71.548% | |
| 2,210.027% | |
| 13.0587% | |
| -6.8846% | |
| -13.4764% | |
| -98.7462% | |
| 278.9915% | |
| -70.0246% | |
| 2.3737% | |
| 22.3893% | |
| -67.1114% | |
| 25.8291% | |
| 53.2705% | |
| 49.6191% | |
| 14.3678% | |
| 33.2641% | |
| 138.3456% | |
| -12.9798% | |
| -7.5964% | |
| 8.1476% | |
| -16.0341% | |
| -21.881% | |
| -14.7105% | |
| -46.7958% | |
| -61.2894% | |
| -0.0481% | |
| 9.5814% | |
| 39.131% | |
| 19.2918% | |
| 5.9153% | |
| -6.4783% | |
| -2.7704% | |
| 39.8766% | |
| 5.5862% | |
| 58.56% | |
| 31.4568% | |
| 13.0681% | |
| 76.9652% | |
| 26.1244% | |
| 25.8723% | |
| -14.4487% | |
| 20.5306% | |
| 13.7112% | |
| 55.4324% | |
| 182.4449% | |
| 12.8906% | |
| -16.6292% | |
| 137.8992% | |
| -201.9582% | |
| 34.4486% | |
| 87.4402% | |
| -468.8306% | |
| 165.7143% | |
| 14.0651% | |
| -8.3516% | |
| -47.0615% | |
| -36.1862% | |
| -45.744% | |
| 1.3877% | |
| 1,494.2774% | |
| 424.8811% | |
| 347.2492% | |
| 335.7384% | |
| 154.2394% | |
| 399.4885% | |
| 28.8712% | |
| 72.4816% | |
| -246.033% | |
| -87.5198% | |
| -35.3458% | |
| -69.5629% | |
| -58.2974% | |
| -3.0746% | |
| 6.3605% | |
| -25.3862% | |
| -26.4141% | |
| -48.0856% | |
| -52.5228% | |
| 100.3009% |